Alberto Tomatis is a dynamic leader at Roche, currently serving as the Director of the Digital InnovationLAB, where he leverages over 15 years of extensive experience in digital innovation, corporate venturing, finance, and procurement. In this pivotal role, Alberto has spearheaded the creation and global...
Alberto Tomatis is a dynamic leader at Roche, currently serving as the Director of the Digital InnovationLAB, where he leverages over 15 years of extensive experience in digital innovation, corporate venturing, finance, and procurement. In this pivotal role, Alberto has spearheaded the creation and global implementation of the Digital InnovationLAB, which has become a cornerstone of Roche's innovation strategy. His efforts have not only garnered recognition as a key driver of innovation within the Roche Group but have also established a robust Innovation Ecosystem that includes 35 global partners spanning academia, technology giants, incubators, and startups. This collaborative framework accelerates the development of digital solutions in critical areas such as personalized healthcare, data analytics, and patient engagement.
Alberto's leadership philosophy is grounded in leading by example, fostering a culture of collaboration and creativity among his diverse teams. His strategic thinking and problem-solving skills are instrumental in navigating the complexities of the digital landscape, ensuring that Roche remains at the forefront of technological advancements in the healthcare sector. By focusing on innovation management and effective communication, he has successfully built a team that thrives on challenges and drives impactful results. Alberto's expertise in business analysis and supplier negotiation further enhances his ability to align digital initiatives with Roche's broader business objectives, ultimately contributing to improved patient outcomes and operational efficiencies. As the Digital InnovationLAB continues to evolve, Alberto remains committed to exploring new frontiers in digital health, ensuring that Roche not only meets the current demands of the industry but also anticipates future trends.
